Stock Analysis

Aprameya Engineering Full Year 2025 Earnings: EPS: ₹9.27 (vs ₹2.49 in FY 2024)

NSEI:APRAMEYA
Source: Shutterstock
Advertisement

Aprameya Engineering (NSE:APRAMEYA) Full Year 2025 Results

Key Financial Results

  • Revenue: ₹1.36b (up 108% from FY 2024).
  • Net income: ₹161.2m (up 362% from FY 2024).
  • Profit margin: 12% (up from 5.4% in FY 2024). The increase in margin was driven by higher revenue.
  • EPS: ₹9.27 (up from ₹2.49 in FY 2024).
revenue-and-expenses-breakdown
NSEI:APRAMEYA Revenue and Expenses Breakdown July 11th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

The primary driver behind last 12 months revenue was the Turnkey Project Supply segment contributing a total revenue of ₹1.25b (92% of total revenue). Notably, cost of sales worth ₹979.9m amounted to 72% of total revenue thereby underscoring the impact on earnings.Explore how APRAMEYA's revenue and expenses shape its earnings.

Aprameya Engineering shares are down 1.8% from a week ago.

Risk Analysis

Before we wrap up, we've discovered 4 warning signs for Aprameya Engineering (2 are significant!) that you should be aware of.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NSEI:APRAMEYA

Aprameya Engineering

Engages in the installation, set up, and maintenance of intensive care units (ICU), neonatal intensive care units (NICU), pediatric intensive care units (PICU), operation theatre, and prefabricated structure wards in the hospitals and medical care centers in India.

Solid track record with adequate balance sheet.

Advertisement